Eversept Partners LP Has $52.77 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Eversept Partners LP lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 36.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 175,808 shares of the company's stock after acquiring an additional 46,724 shares during the quarter. HCA Healthcare makes up 4.7% of Eversept Partners LP's holdings, making the stock its 5th biggest holding. Eversept Partners LP owned about 0.07% of HCA Healthcare worth $52,769,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently added to or reduced their stakes in the company. Whipplewood Advisors LLC bought a new stake in HCA Healthcare in the 4th quarter valued at about $31,000. Tidemark LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at $36,000. Activest Wealth Management raised its position in HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after acquiring an additional 125 shares during the period. Pinnacle Bancorp Inc. grew its holdings in HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after purchasing an additional 50 shares during the period. Finally, Eastern Bank purchased a new stake in HCA Healthcare in the 4th quarter worth about $62,000. Institutional investors own 62.73% of the company's stock.

Insider Buying and Selling

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.30% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Truist Financial decreased their price objective on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. Barclays dropped their price target on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a research report on Monday, January 27th. Royal Bank of Canada lowered their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating on the stock in a research note on Monday, January 27th. Robert W. Baird reissued a "neutral" rating and issued a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Finally, Bank of America cut their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $381.67.

HCA Healthcare Trading Down 4.0 %

HCA stock traded down $13.72 during trading on Friday, reaching $327.69. The company had a trading volume of 2,803,570 shares, compared to its average volume of 1,394,578. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The business has a 50 day moving average of $329.82 and a 200 day moving average of $331.76. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The company has a market cap of $80.68 billion, a P/E ratio of 14.92, a PEG ratio of 1.10 and a beta of 1.48.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping the consensus estimate of $5.77 by $0.68. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The company had revenue of $18.32 billion for the quarter, compared to analysts' expectations of $18.26 billion. During the same period in the prior year, the firm earned $5.36 earnings per share. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.88%. HCA Healthcare's payout ratio is 12.81%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.